Literature DB >> 17072629

Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.

Rotraut Mössner1, Nils Anders, Inke R König, Ullrich Krüger, Diane Schmidt, Carola Berking, Andreas Ziegler, Jürgen Brockmöller, Rolf Kaiser, Matthias Volkenandt, Götz A Westphal, Kristian Reich.   

Abstract

Variations in the melanocortin-1 receptor (MC1R) and in the glutathione-S transferase genes mu1 (GSTM1) and theta 1 (GSTT1) have been reported to influence UV sensitivity and melanoma risk. MC1R is one of the major genes that determine skin pigmentation because the melanocortin-1 receptor regulates eumelanin synthesis. GSTT1 and GSTM1 are enzymes expressed in the skin that detoxify products of oxidative stress reactions caused by UV irradiation. In this study variations in the MC1R, GSTM1 and T1 genes were analyzed in 347 healthy subjects and 322 patients with cutaneous malignant melanoma by direct cycle sequencing, RFLP and multiplex PCR. Important phenotypic characteristics of the study participants were obtained to assess whether genetic associations occurred independently of phenotypic risk factors for melanoma. We found an association of the MC1R D84E and R151C polymorphisms with melanoma (odds ratios for carriage of the rare allele 4.96, 95% CI [1.06-23.13], P = 0.032, and 1.69, 95% CI [1.12-2.55], P = 0.013, respectively). Melanoma risk increased with the number of variant MC1R alleles carried by an individual (P = 0.003). In a multivariate model, however, only the D84E polymorphism influenced melanoma risk independently of the risk factors fair skin type, high nevus count and high age (P = 0.047). There was no effect of homozygous GST M1 or T1 deletions on melanoma risk. In contrast to previous data, there was no evidence that GSTM1 deficiency influences melanoma risk in the subgroup of individuals with red or blond hair.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072629     DOI: 10.1007/s00403-006-0708-7

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  13 in total

1.  MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium.

Authors:  Alexander J Stratigos; Maria Concetta Fargnoli; Arcangela De Nicolo; Ketty Peris; Susana Puig; Efthymia Soura; Chiara Menin; Donato Calista; Paola Ghiorzo; Mario Mandala; Daniela Massi; Monica Rodolfo; Laura Del Regno; Irene Stefanaki; Helen Gogas; Veronique Bataille; Margaret A Tucker; David Whiteman; Eduardo Nagore; Maria Teresa Landi
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-09-14       Impact factor: 6.166

2.  Contribution of glutathione S-transferase gene polymorphisms to development of skin cancer.

Authors:  Zeyuan Lei; Ting Liu; Xiang Li; Xiaoxia Xu; Dongli Fan
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  The neuropeptide alpha-melanocyte-stimulating hormone is critically involved in the development of cytotoxic CD8+ T cells in mice and humans.

Authors:  Karin Loser; Thomas Brzoska; Vinzenz Oji; Matteo Auriemma; Maik Voskort; Verena Kupas; Lars Klenner; Cornelius Mensing; Axel Hauschild; Stefan Beissert; Thomas A Luger
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

4.  GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese.

Authors:  Xiuchan Guo; Stephen J O'Brien; Yi Zeng; George W Nelson; Cheryl A Winkler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

5.  A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes.

Authors:  Yu-mei Chang; Julia A Newton-Bishop; D Timothy Bishop; Bruce K Armstrong; Veronique Bataille; Wilma Bergman; Marianne Berwick; Paige M Bracci; J Mark Elwood; Marc S Ernstoff; Adèle C Green; Nelleke A Gruis; Elizabeth A Holly; Christian Ingvar; Peter A Kanetsky; Margaret R Karagas; Loïc Le Marchand; Rona M Mackie; Håkan Olsson; Anne Østerlind; Timothy R Rebbeck; Kristian Reich; Peter Sasieni; Victor Siskind; Anthony J Swerdlow; Linda Titus-Ernstoff; Michael S Zens; Andreas Ziegler; Jennifer H Barrett
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

6.  Protective effect of copy number polymorphism of glutathione S-transferase T1 gene on melanoma risk in presence of CDKN2A mutations, MC1R variants and host-related phenotypes.

Authors:  Valérie Chaudru; M T Lo; F Lesueur; C Marian; H Mohamdi; K Laud; M Barrois; A Chompret; M F Avril; F Demenais; B Bressac-de Paillerets
Journal:  Fam Cancer       Date:  2009-05-31       Impact factor: 2.375

7.  In silico mutagenesis: a case study of the melanocortin 4 receptor.

Authors:  Yana Bromberg; John Overton; Christian Vaisse; Rudolph L Leibel; Burkhard Rost
Journal:  FASEB J       Date:  2009-05-05       Impact factor: 5.191

8.  Effect of GSTM1 polymorphism on risks of basal cell carcinoma and squamous cell carcinoma: a meta-analysis.

Authors:  Hao Peng; Quanyong He; Jie Zhu; Cheng Peng
Journal:  Tumour Biol       Date:  2012-11-27

9.  Development and validation of a melanoma risk score based on pooled data from 16 case-control studies.

Authors:  John R Davies; Yu-mei Chang; D Timothy Bishop; Bruce K Armstrong; Veronique Bataille; Wilma Bergman; Marianne Berwick; Paige M Bracci; J Mark Elwood; Marc S Ernstoff; Adele Green; Nelleke A Gruis; Elizabeth A Holly; Christian Ingvar; Peter A Kanetsky; Margaret R Karagas; Tim K Lee; Loïc Le Marchand; Rona M Mackie; Håkan Olsson; Anne Østerlind; Timothy R Rebbeck; Kristian Reich; Peter Sasieni; Victor Siskind; Anthony J Swerdlow; Linda Titus; Michael S Zens; Andreas Ziegler; Richard P Gallagher; Jennifer H Barrett; Julia Newton-Bishop
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-02-24       Impact factor: 4.254

Review 10.  Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.

Authors:  Jerry D Monroe; Faiza Basheer; Yann Gibert
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.